Perjeta Chemotherapy Information

If you have breast cancer, your healthcare provider may prescribe PerjetaTM (pertuzumab). This medicine is specifically approved for use in adults, and must be used in combination with certain other medications. Perjeta is designed to treat breast cancer that has spread to other areas of the body (metastasized) and that expresses a specific type of protein on the cancer cells.
 
Perjeta is given as an intravenous (IV) infusion. A healthcare provider will administer the medicine in a healthcare setting, such as a hospital. This medication is usually given once every three weeks.
 
Before receiving Perjeta, make sure to review the medication's safety information with your healthcare provider. Unlike many other cancer treatments that are a type of chemotherapy, Perjeta is a biologic therapy. It is less "toxic" than chemotherapy, as it specifically targets certain receptors on the cancer cells. Because it is only used to treat cancers that have a high concentration of these receptors, it targets the tumors, having less of an effect on healthy, noncancerous cells.
 
(Click Perjeta for more information on this medication, including why it is not a form of chemotherapy and what to expect during treatment.)
 

Perjeta Chemotherapy Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.